Cipla Limited (CIPLA) — Board Meeting Announcement

· NSE 🟡 Notable Neutral
📢 Key Event
Appointment of Shivam Puri as CEO of One India Business and grant of stock options and ESARs.
🔄 What Changed
New CEO appointment and employee stock option grants.
🔮 What's Next
Effective 1 July 2026 for CEO role; vesting periods specified for options and ESARs.
💡 Investor Takeaway
Leadership change aims to strengthen One India Business growth and employee incentives.

Cipla announced the appointment of Shivam Puri as CEO of One India Business effective 1 July 2026 and granted 11,360 stock options and 51,394 ESARs under its employee benefit schemes, with vesting periods of two and three years respectively and an exercise price of INR 2 per share.

📄 View Original Announcement (PDF)

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.